Capital raised by X1 Biotech
1 Form D filing · first filed May 2026 · Needham, MA
President and CEO
Signatory on X1 Biotech's Form D filings · $40K raised across 1
Lawrence Kaufman is on file as President and CEO at X1 Biotech in Needham, MA. X1 Biotech has 1 Form D filing on record, $40K raised in total. Lawrence Kaufman appears as a signatory on the company's filings.
A repurposed small-molecule RUNX1 inhibitor (Ro24-7429) being developed first for CADASIL, an inherited cerebral small-vessel disease, with expansion planned into other vascular-degeneration and fibrotic indications.
